Status:
WITHDRAWN
SARS-CoV-2 (COVID-19) Detection Using the Breath Analizer TeraSystem
Lead Sponsor:
Instituto Costarricense de Investigaciones Clínicas ICIC
Conditions:
COVID19
Eligibility:
All Genders
7+ years
Brief Summary
The purpose of the study is to verify the sensibility and accuracy of a rapid detection test for SARS-CoV-2 in breath samples analyzed by the breath detector analyzer TeraSystem, comparing with PCR te...
Detailed Description
BioSafety Technologies has developed a rapid detection test to clear people of COVID-19. A person can undergo an easy non-invasive test, to determine if they are: COVID-19 Clear (Negative) or Infecte...
Eligibility Criteria
Inclusion
- Older than 7 years odf age Able to provide informed consent Able to take the breath test
Exclusion
- Younger than 7 years of age Unable to provide informed consent Unable to take the breath test
Key Trial Info
Start Date :
November 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04497610
Start Date
November 1 2022
End Date
November 1 2022
Last Update
November 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Costarricense de Investigaciones Clínicas
San José, Costa Rica